NCT04462484 (MAGO) is a NA clinical trial of videoconference in Occupational Burnout, sponsored by University of Padova.

Who is sponsoring NCT04462484?

NCT04462484 is sponsored by University of Padova.

What drugs are being tested in NCT04462484?

Interventions in NCT04462484: videoconference.

What condition does NCT04462484 study?

NCT04462484 studies Occupational Burnout.

Is NCT04462484 still recruiting?

NCT04462484 is currently completed. Last updated 20 May 2022.

Last reviewed 2022-05-20 · How we verify

NCT04462484: MAGO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Online Self-care Training Program (MAGO Study)

Completed NA Last updated 20 May 2022

What this trial tests

NA trial testing videoconference in Occupational Burnout in 74 participants. Completed in 13 February 2022.

Timeline

14 July 2020

Primary endpoint
13 February 2022

13 February 2022

Quick facts

Lead sponsor	University of Padova
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	74
Start date	14 July 2020
Primary completion	13 February 2022
Estimated completion	13 February 2022
Sites	1 location across Chile

Drugs / interventions tested

videoconference

Conditions studied

Occupational Burnout — all drugs for Occupational Burnout →

Sponsor

University of Padova

Who can join

18 and older, any sex, with Occupational Burnout. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to determine the efficacy of MAGO (Online Self-care Training Program for Psychologists), a person-directed, individual, occupational intervention via videoconference in six sessions on a weekly basis. By promoting self-care behaviors, it is expected to reduce burnout levels and to increase work engagement in clinical psychologists working in Chile.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Padova trials

Trials by the same sponsor.

NCT07435064 — NURsing-led FRAILty Prevention and Care · NA · not yet recruiting
NCT07283354 — Comparison of Acceleromyography and Electromyography in Obese Patients Undergoing General Anesthesia · not yet recruiting
NCT07259460 — Effects of Dexmedetomidine Target Controlled Infusion on Patient State Index Values and Electroencephalographic Spectrum · recruiting
NCT07385118 — Daily Fluctuations in Brain-Derived Neurotrophic Factor and Cognition: Effects of Vigorous Exercise · NA · completed
NCT07259291 — Minto and Eleveld Remifentanil Target Controlled Infusion (TCI) Models: a Clinical Comparison · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04462484 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Padova
Last refreshed: 20 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04462484.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing